CAS 160498-02-2: 2(5H)-Furanone,5-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]-1-(2,5-dihydro-2-oxo-3-furanyl)ethyl]-3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethenyl]-(9CI)

Bisandrographolide C is a bioactive diterpenoid, which is an extract derived from the plant Andrographis paniculata, commonly known as the "king of bitters." This plant is a member of the Acanthaceae family, widely used in traditional medicine for its diverse therapeutic properties. Bisandrographolide C functions primarily through its anti-inflammatory and immunomodulatory mechanisms. It acts by modulating key signaling pathways, thereby inhibiting the production of pro-inflammatory mediators and enhancing immune responses. The compound is employed in research settings to explore its potential benefits in treating inflammatory conditions and infections. Studies have shown its efficacy in modulating immune responses, suggesting applications in autoimmune diseases and as an adjunct in infectious disease therapy. Due to its complex mode of action and origin, Bisandrographolide C continues to be an essential subject of research for scientists aiming to develop novel therapeutic agents.

Bisandrographolide C from Andrographis paniculata triggers TRPV1/TRPV3; aids heart cells in low-oxygen stress. (Kds: 289/341 μM)